
Eloxx Pharmaceuticals is a biotechnology business based in the US. Eloxx Pharmaceuticals shares (ELOX) are listed on the NASDAQ and all prices are listed in US Dollars. Eloxx Pharmaceuticals employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Eloxx Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ELOX. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Eloxx Pharmaceuticals stock price (NASDAQ: ELOX)
Use our graph to track the performance of ELOX stocks over time.Eloxx Pharmaceuticals shares at a glance
Latest market close | $4.18 |
---|---|
52-week range | $1.70 - $24.60 |
50-day moving average | $3.85 |
200-day moving average | $9.60 |
Wall St. target price | $120.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.85 |
Buy Eloxx Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Eloxx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Eloxx Pharmaceuticals price performance over time
Historical closes compared with the close of $4.18 from 2023-01-27
1 week (2023-01-20) | 6.36% |
---|---|
1 month (2022-12-28) | 134.83% |
3 months (2022-10-28) | 2,512.50% |
6 months (2022-07-28) | 1,418.90% |
1 year (2022-01-27) | 835.12% |
---|---|
2 years (2021-01-28) | 17.09% |
3 years (2020-01-28) | 4.76% |
5 years (2018-01-26) | 8.25 |
Eloxx Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -60.81% |
Return on equity TTM | -298.66% |
Profit margin | 0% |
Book value | $-2.30 |
Market capitalisation | $9.1 million |
TTM: trailing 12 months
Eloxx Pharmaceuticals share dividends
We're not expecting Eloxx Pharmaceuticals to pay a dividend over the next 12 months.
Have Eloxx Pharmaceuticals's shares ever split?
Eloxx Pharmaceuticals's shares were split on a 1:40 basis on 1 December 2022. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eloxx Pharmaceuticals shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Eloxx Pharmaceuticals shares which in turn could have impacted Eloxx Pharmaceuticals's share price.
Eloxx Pharmaceuticals share price volatility
Over the last 12 months, Eloxx Pharmaceuticals's shares have ranged in value from as little as $1.6959 up to $24.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eloxx Pharmaceuticals's is 2.2497. This would suggest that Eloxx Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Eloxx Pharmaceuticals overview
Eloxx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts. .
Eloxx Pharmaceuticals in the news
Eloxx Pharmaceuticals Announces First Patients Enrolled in Phase 2 Clinical Study Evaluating ELX-02 for the Treatment of Alport Syndrome
Eloxx Pharmaceuticals Announces First Patients Enrolled in Phase 2 Clinical Study Evaluating ELX-02 for the Treatment of Alport Syndrome
Frequently asked questions
What percentage of Eloxx Pharmaceuticals is owned by insiders or institutions?Currently 12.109% of Eloxx Pharmaceuticals shares are held by insiders and 40.599% by institutions. How many people work for Eloxx Pharmaceuticals?
Latest data suggests 28 work at Eloxx Pharmaceuticals. When does the fiscal year end for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals's fiscal year ends in December. Where is Eloxx Pharmaceuticals based?
Eloxx Pharmaceuticals's address is: 480 Arsenal Way, Watertown, MA, United States, 02472 What is Eloxx Pharmaceuticals's ISIN number?
Eloxx Pharmaceuticals's international securities identification number is: US29014R1032 What is Eloxx Pharmaceuticals's CUSIP number?
Eloxx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 817208408
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert